Free Trial

NewGenIvf Group (NIVF) Competitors

NewGenIvf Group logo
$2.63 0.00 (0.00%)
As of 11:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NIVF vs. OTRK, SSY, BGLC, ACON, DHAC, VSEE, ATIP, BACK, BTTX, and UPHL

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Ontrak (OTRK), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), Vsee Health (VSEE), ATI Physical Therapy (ATIP), IMAC (BACK), Better Therapeutics (BTTX), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs.

NewGenIvf Group (NASDAQ:NIVF) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 12.9% of Ontrak shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Comparatively, 1.9% of Ontrak shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ontrak received 38 more outperform votes than NewGenIvf Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NewGenIvf GroupN/AN/A
OntrakOutperform Votes
38
59.38%
Underperform Votes
26
40.63%

In the previous week, Ontrak had 5 more articles in the media than NewGenIvf Group. MarketBeat recorded 5 mentions for Ontrak and 0 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 0.00 beat Ontrak's score of -0.29 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company Overall Sentiment
NewGenIvf Group Neutral
Ontrak Neutral

Ontrak has a consensus target price of $45.00, suggesting a potential upside of 2,766.24%. Given Ontrak's stronger consensus rating and higher probable upside, analysts clearly believe Ontrak is more favorable than NewGenIvf Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Ontrak
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NewGenIvf Group has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.3, suggesting that its share price is 130% more volatile than the S&P 500.

NewGenIvf Group has a net margin of 0.00% compared to Ontrak's net margin of -237.77%. NewGenIvf Group's return on equity of 0.00% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Ontrak -237.77%-171.34%-113.42%

NewGenIvf Group has higher earnings, but lower revenue than Ontrak.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$5.43M0.26$130KN/AN/A
Ontrak$10.85M0.61-$27.92M-$15.81-0.10

Summary

Ontrak beats NewGenIvf Group on 8 of the 15 factors compared between the two stocks.

Get NewGenIvf Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$1.39M$2.03B$5.31B$8.42B
Dividend YieldN/A6.99%5.21%4.10%
P/E RatioN/A15.9026.7819.69
Price / Sales0.263.42386.97118.34
Price / Cash3.119.3238.2534.62
Price / Book1.203.906.744.50
Net Income$130,000.00$87.49M$3.23B$248.32M
7 Day Performance-11.74%-6.37%1.49%-0.03%
1 Month Performance-15.16%-6.85%11.47%12.72%
1 Year Performance-98.87%-30.52%16.57%7.38%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
1.0104 of 5 stars
$2.63
flat
N/A-98.9%$1.39M$5.43M0.00N/A
OTRK
Ontrak
2.5265 of 5 stars
$1.58
+1.9%
$45.00
+2,748.1%
-61.2%$6.66M$10.85M-0.15250News Coverage
Earnings Report
Gap Up
SSY
SunLink Health Systems
N/A$0.86
+4.1%
N/A+42.5%$6.06M$31.23M6.141,376News Coverage
Analyst Forecast
Gap Up
BGLC
BioNexus Gene Lab
0.2595 of 5 stars
$2.69
-5.6%
N/A-44.9%$4.83M$9.51M0.0030Negative News
Earnings Report
ACON
Aclarion
1.6392 of 5 stars
$7.17
+3.3%
$11,758.50
+163,895.8%
-99.8%$4.17M$45,724.000.007Positive News
Earnings Report
DHAC
Digital Health Acquisition
N/A$1.11
+1.5%
N/A-91.4%$4MN/A0.002,021
VSEE
Vsee Health
1.1856 of 5 stars
$1.08
-2.6%
$5.00
+362.5%
N/A$4M$6.38M0.00N/AGap Up
ATIP
ATI Physical Therapy
N/A$0.90
flat
N/A-81.3%$3.97M$741.86M-0.055,600
BACK
IMAC
N/A$0.04
+15.2%
N/A-99.1%$75,000.00$72,050.000.00180
BTTX
Better Therapeutics
N/A$0.00
flat
N/A-99.1%$10,000.00N/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-99.9%$4,000.00$130M0.001,750Gap Up

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners